Does Rallies track congressional trades in TMO?

Yes. Rallies tracks politician and congressional stock disclosures for TMO, including reported purchases, sales, dates, owners, and trade amounts when available.

Is TMO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TMO. It does not provide personalized investment advice.

TMO (Thermo Fisher) Stock Analysis - Politician Trades

Thermo Fisher (TMO) is a publicly traded Healthcare sector company. As of May 20, 2026, TMO trades at $449.99 with a market cap of $164.26B and a P/E ratio of 24.62. TMO moved +0.93% today. Year to date, TMO is -24.42%; over the trailing twelve months it is +8.19%. Its 52-week range spans $385.46 to $643.99. Analyst consensus is strong buy with an average price target of $611.60. Rallies surfaces TMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded TMO stock?

Recent politician trading activity in TMO includes disclosures from Ro Khanna, Ro Khanna, Angus King, Richard W. Allen, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

TMO Key Metrics

Key financial metrics for TMO
Metric	Value
Price	$449.99
Market Cap	$164.26B
P/E Ratio	24.62
EPS	$18.22
Dividend Yield	0.47%
52-Week High	$643.99
52-Week Low	$385.46
Volume	2.42M
Avg Volume	0
Revenue (TTM)	$45.20B
Net Income	$6.87B
Gross Margin	0.00%

Congressional Trades in TMO

Ro Khanna purchase TMO on Mar 6, 2026 (amount: $15.00K).
Ro Khanna purchase TMO on Jul 30, 2025 (amount: $15.00K).
Angus King sale (full) TMO on Jul 21, 2025 (amount: $15.00K) for Spouse.
Richard W. Allen sale TMO on May 16, 2025 (amount: $50.00K) for Spouse.
Rob Bresnahan purchase TMO on May 15, 2025 (amount: $50.00K).

Latest TMO News

Thermo Fisher Q1 Revenue Hits $11.01B, EPS Beats Estimates, Flags Inflation Risk — Apr 23, 2026
Thermo Fisher slides as Q1 organic growth stays muted despite reported revenue gain — Apr 23, 2026
Thermo Fisher Q1 Revenue Rises 6% to $11.01B; EPS Up and $3B Buyback — Apr 23, 2026
Thermo Fisher slides as price-target cut revives growth worries after Clario deal close — Apr 16, 2026
Thermo Fisher jumps as Clario deal momentum builds ahead of April 23 earnings — Apr 14, 2026

Recent TMO Insider Trades

Pettiti Gianluca sold 400 (~$185.06K) on Apr 27, 2026.
Shafer Michael D sold 1.61K (~$802.54K) on Mar 11, 2026.
CASPER MARC N sold 20 (~$10.07K) on Mar 5, 2026.

TMO Analyst Consensus

17 analysts cover TMO: 0 strong buy, 15 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $611.60.

Common questions about TMO

Which politicians traded TMO stock?: Recent politician trading activity in TMO includes disclosures from Ro Khanna, Ro Khanna, Angus King, Richard W. Allen, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in TMO?: Yes. Rallies tracks politician and congressional stock disclosures for TMO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TMO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TMO. It does not provide personalized investment advice.